Diagnostic and therapeutic approaches for elderly asthma patients: the importance of multidisciplinary and multidimensional management

INTRODUCTION Asthma is commonly considered a disease of younger ages; however, it is not infrequent to pose a diagnosis of the disease in older individuals. Although current recommendations do not distinguish between young and old asthmatics in terms of diagnostic and therapeutic approaches, asthma in the elderly may present with peculiar features that contribute to complicate its management. AREAS COVERED The current review focuses on the challenges that arise when approaching an older individual with suspected asthma. Age-associated changes of the lung may complicate the diagnostic approach. Measurement of the forced expiratory volume in the first 6 seconds (FEV6) in an easier and faster alternative to FVC estimation, and residual volume should always be assessed. Older individuals are often affected by concomitant diseases, both age and drug-related, that need to be considered when approaching elderly asthmatics, since they can affect the efficacy of the treatment as well as the control of the disease. EXPERT OPINION The potential drug to drug interaction should be routinely investigated, and documented in medical records. The effect of aging on the response to pharmacological therapy in older asthmatics should be explored. Therefore, the need of a multidisciplinary and multidimensional approach to the elderly asthmatics is strongly encouraged.

[1]  T. Soma,et al.  Immunosenescence, Inflammaging, and Lung Senescence in Asthma in the Elderly , 2022, Biomolecules.

[2]  Benoni Roberto,et al.  Clinical response to biologics for severe asthma: any relevance for sex in different age ranges? , 2022, ERJ Open Research.

[3]  A. Didier,et al.  Self-reported asthma prevalence and management in adults in France in 2018: ASTHMAPOP survey. , 2021, Respiratory medicine and research.

[4]  N. Ghani,et al.  Multi-Dimensional Assessment and Interdisciplinary Care to Reduce Asthma Readmissions in Safety Net Hospitals , 2021, Respiratory Care.

[5]  K. Nakagome,et al.  Relationship between airway inflammation and airflow limitation in elderly asthmatics , 2020, Asia Pacific allergy.

[6]  N. Scichilone,et al.  Age does not affect the efficacy of anti-IL-5/IL-5R in severe asthmatics , 2019, The World Allergy Organization journal.

[7]  M. Pihlsgård,et al.  Relative and absolute lung function change in a general population aged 60–102 years , 2019, European Respiratory Journal.

[8]  C. Porsbjerg,et al.  Co‐morbidities in severe asthma: Clinical impact and management , 2017, Respirology.

[9]  A. Çilli,et al.  Evaluation of long-term safety and efficacy of omalizumab in elderly patients with uncontrolled allergic asthma. , 2016, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[10]  G. Rolla,et al.  Effects of omalizumab in severe asthmatics across ages: A real life Italian experience. , 2016, Respiratory medicine.

[11]  B. Rogala,et al.  Asthma, COPD and comorbidities in elderly people , 2016, The Journal of asthma : official journal of the Association for the Care of Asthma.

[12]  N. Scichilone,et al.  Challenges in the pharmacological treatment of geriatric asthma , 2016, Expert review of clinical pharmacology.

[13]  N. Scichilone,et al.  Asthma in the elderly: a different disease? , 2016, Breathe.

[14]  L. Boulet Asthma in the elderly patient , 2016, Asthma Research and Practice.

[15]  N. Scichilone,et al.  The geriatric asthma: pitfalls and challenges , 2016, Asthma Research and Practice.

[16]  J. Nadel,et al.  Unraveling the Pathophysiology of the Asthma-COPD Overlap Syndrome: Unsuspected Mild Centrilobular Emphysema Is Responsible for Loss of Lung Elastic Recoil in Never Smokers With Asthma With Persistent Expiratory Airflow Limitation. , 2015, Chest.

[17]  M. Kowalski,et al.  Comorbidities in elderly patients with asthma: Association with control of the disease and concomitant treatment , 2015, Geriatrics & Gerontology International.

[18]  N. Scichilone,et al.  Safety Considerations of Inhaled Corticosteroids in the Elderly , 2014, Drugs & Aging.

[19]  C. Franceschi,et al.  Chronic inflammation (inflammaging) and its potential contribution to age-associated diseases. , 2014, The journals of gerontology. Series A, Biological sciences and medical sciences.

[20]  E. Halm,et al.  Depressive Symptoms, Low Adherence, and Poor Asthma Outcomes in the Elderly , 2013, The Journal of asthma : official journal of the Association for the Care of Asthma.

[21]  M. King,et al.  Asthma Prevalence among US Elderly by Age Groups: Age Still Matters , 2012, The Journal of asthma : official journal of the Association for the Care of Asthma.

[22]  T. To,et al.  Pulmonary function testing in the diagnosis of asthma: a population study. , 2012, Chest.

[23]  W. Busse,et al.  Omalizumab and the risk of malignancy: results from a pooled analysis. , 2012, The Journal of allergy and clinical immunology.

[24]  B. Yawn,et al.  Asthma in the elderly: Current understanding and future research needs—a report of a National Institute on Aging (NIA) workshop , 2011, Journal of Allergy and Clinical Immunology.

[25]  L. Boulet,et al.  Asthma-related comorbidities , 2011, Expert review of respiratory medicine.

[26]  P. Austin,et al.  Inhaled anticholinergic drug therapy and the risk of acute urinary retention in chronic obstructive pulmonary disease: a population-based study. , 2011, Archives of internal medicine.

[27]  A. Togias,et al.  The impact of age on prevalence of positive skin prick tests and specific IgE tests. , 2011, Respiratory medicine.

[28]  S. Suissa,et al.  Inhaled corticosteroids and the risks of diabetes onset and progression. , 2010, The American journal of medicine.

[29]  M. Miller,et al.  Structural and physiological age-associated changes in aging lungs. , 2010, Seminars in respiratory and critical care medicine.

[30]  K. Stoiber,et al.  Effectiveness of omalizumab in patients 50 years and older with severe persistent allergic asthma. , 2010, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[31]  Graziano Onder,et al.  Development and validation of a score to assess risk of adverse drug reactions among in-hospital patients 65 years or older: the GerontoNet ADR risk score. , 2010, Archives of internal medicine.

[32]  Nicholas Moore,et al.  Drug interactions between inhaled corticosteroids and enzymatic inhibitors , 2009, European Journal of Clinical Pharmacology.

[33]  M. Weatherall,et al.  Dose–response relationship for risk of non‐vertebral fracture with inhaled corticosteroids , 2008, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[34]  Tonya S. King,et al.  Aeroallergen sensitization correlates with PC(20) and exhaled nitric oxide in subjects with mild-to-moderate asthma. , 2008, The Journal of allergy and clinical immunology.

[35]  F. Kianifard,et al.  Response of Older Patients with IgE-Mediated Asthma to Omalizumab: A Pooled Analysis , 2008, The Journal of asthma : official journal of the Association for the Care of Asthma.

[36]  R. Pistelli,et al.  Validation of FEV6 in the elderly: correlates of performance and repeatability , 2007, Thorax.

[37]  C. Wentworth,et al.  Pooled clinical trial analysis of tiotropium safety. , 2006, Chest.

[38]  A. Hansell,et al.  Patterns of comorbidities in newly diagnosed COPD and asthma in primary care. , 2005, Chest.

[39]  N. Scichilone,et al.  Airway hyperresponsiveness in the elderly: prevalence and clinical implications , 2005, European Respiratory Journal.

[40]  L. Boulet,et al.  Efficacy and tolerability of anti‐immunoglobulin E therapy with omalizumab in patients with concomitant allergic asthma and persistent allergic rhinitis: SOLAR , 2004, Allergy.

[41]  J. Bousquet,et al.  Efficacy and safety of a recombinant anti‐immunoglobulin E antibody (omalizumab) in severe allergic asthma , 2004, Clinical and experimental allergy : journal of the British Society for Allergy and Clinical Immunology.

[42]  F. Rengo,et al.  Aging and disability affect misdiagnosis of COPD in elderly asthmatics: the SARA study. , 2003, Chest.

[43]  R. Norman,et al.  Asthma in the elderly: cockroach sensitization and severity of airway obstruction in elderly nonsmokers. , 2002, Chest.

[44]  N. Zamel,et al.  Unsuspected loss of lung elastic recoil in chronic persistent asthma. , 2002, Chest.

[45]  G. Bonsignore,et al.  Changes in FVC during methacholine-induced bronchoconstriction in elderly patients with asthma: bronchial hyperresponsiveness and aging. , 2001, Chest.

[46]  M. Nieminen,et al.  Increase of asthma in adults in northern Finland?– a report from the FinEsS study , 2001, Allergy.

[47]  S. Suissa,et al.  Association of inhaled corticosteroid use with cataract extraction in elderly patients. , 1998, JAMA.

[48]  J D Best,et al.  Differential changes of autonomic nervous system function with age in man. , 1983, The American journal of medicine.

[49]  Sang-Heon Cho,et al.  Classification and implementation of asthma phenotypes in elderly patients. , 2015, Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology.

[50]  J. Castro‐Rodriguez,et al.  Efficacy and safety of subcutaneous omalizumab vs placebo as add-on therapy to corticosteroids for children and adults with asthma: a systematic review. , 2011, Chest.

[51]  D. Postma,et al.  Chronic respiratory symptoms and airway responsiveness to methacholine are associated with eosinophilia in older men: the Normative Aging Study. , 1995, The European respiratory journal.